Deep Track Capital, LP Dice Therapeutics, Inc. Transaction History

Deep Track Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $3.49 Million - $4.33 Million	-134,143 Reduced 7.74%	1,600,000 $45.8 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $14.5 Million - $31 Million	734,143 Added 73.41%	1,734,143 $54.1 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $642,213 - $971,684	-42,900 Reduced 4.11%	1,000,000 $20.3 Million
Q2 2022 Aug 12, 2022	SELL	$13.19 - $22.1 $2.73 Million - $4.58 Million	-207,100 Reduced 16.57%	1,042,900 $16.2 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $1.32 Million - $2.28 Million	-91,004 Reduced 6.79%	1,250,000 $23.9 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $30.1 Million - $50.3 Million	1,341,004 New	1,341,004 $33.9 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.